alpha-aminopyridine has been researched along with Laryngeal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, J; Chen, X; Ge, J; Guo, X; Guo, Y; Li, L; Li, W; Liu, M; Liu, X; Shao, Y; Tian, L; Xu, L; Yang, Z; Zhang, J; Zhao, R | 1 |
1 other study(ies) available for alpha-aminopyridine and Laryngeal Neoplasms
| Article | Year |
|---|---|
Chidamide, a novel histone deacetylase inhibitor, inhibits laryngeal cancer progression in vitro and in vivo.
Topics: Aminopyridines; Animals; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Histone Deacetylase Inhibitors; Humans; Laryngeal Neoplasms; Quality of Life | 2023 |